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INTRODUCTION
Body fluid shifts are commonplace in chronic hemodialysis
(HD) patients during the intra- and interdialytic periods, and
are associated with dialysis-related complications (1). A great
challenge for physicians caring for HD patients is accurately
assessing volume status. Not surprisingly, clinical determi-
nation of dry weight results in substantial error (2). There
are several methods for assessing balance and shift of body
fluid in HD patients, such as those involving the biochemi-
cal markers (ex. cyclic guanosine monophosphate [cGMP],
atrial natriuretic peptide [ANP], brain natriuretic peptide
[BNP]), inferior vena cava (IVC) diameter, bioimpedance
analysis (BIA) and blood volume monitoring (BVM) (2, 3).
Biochemical markers of volume overload are fraught with
excessive variability and poor correlation with volume status
(4, 5). Another limitation of using these markers is the inabili-
ty to detect volume depletion, since there are no differences
in values between normovolemia and hypovolemia. IVC ultra-
sound is effective, but has several limitations (6-9).
BIA, a simple non-invasive method of assessing body com-
position has been used to determine the compartmental dis-
tribution of body fluid including intracelluar fluid (ICF),
extracellular fluid (ECF) and total body water (TBW) (10-
12). However, BIA can not differentiate the amounts and
changes of the intravascular volume from those of ECF.
BVM is helpful in estimating the relative changes of the
intravascular volume whereas BVM can not identify the
absolute changes of the intravascular volume and other fluid
compartment during HD (2). That can measure the blood
volume only in the ratio of relative volume to the predialysis
blood volume (14). For this reason, we think the combina-
tion method using BIA and BVM is superior to each of the
methods alone in assessing the changes and shifts of the fluid
compartment during HD.
Else, two recent studies (15, 16) showed contradictory
results in assessing fluid changes of body segments during
hemodialysis. One study (15) showed fluid reduction of legs
was the greatest whereas another study (16) reported fluid
removal of trunk was higher than extremity during hemodial-
ysis.
So, in this study, we evaluated fluid shifts of body com-
partments using both BIA and BVM from the start to the
end of hemodialysis.
MATERIALS AND METHODS
Patient characteristics
Twenty four stable HD patients with fixed dry weight (14
men and 10 women; 10 diabetic and 14 non-diabetic) at Dr.
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Assessment of Fluid Shifts of Body Compartments using Both
Bioimpedance Analysis and Blood Volume Monitoring
Fluid shifts are commonplace in chronic hemodialysis patients during the intra- and
interdialytic periods. In this study, we evaluated fluid shifts of body compartments
using both bioimpedance spectroscopy and blood volume monitoring from the start
to the end of hemodialysis. 24 stable hemodialysis patients were included on the
study. Relative change of blood volume was progressively reduced from the start
to the end of hemodialysis (1 hr, -7.22±3.23%; 2 hr, -9.78±4.69%; 3 hr, -12.88±
5.65%; 4 hr, -15.41±6.54%, respectively). Mean % reduction of intracellular fluid
was not significantly different to that of extracellular fluid at the end of hemodialysis
( ICF, -6.58±5.34% vs.  ECF, -7.07±5.12%). Mean % fluid reduction of arms,
legs and trunk was -11.98±6.76%, -6.43±4.37% and -7.47±4.56%, respectively
at the end of hemodialysis. There were 3 characteristic patterns in blood-volume
change. Similar amounts of fluid were removed from the extracellular and intracellu-
lar compartments during hemodialysis, with the arms showing the greatest loss in
terms of body segments. The pattern of blood volume change measured by blood
volume monitoring may be useful for more accurate determination of dry-weight
and for correcting volume status in hemodialysis patients.
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Kang’s Dialysis Center were participated in this study. Patients
within 6 months of starting dialysis therapy, clinical signs
of overhydration (predialysis mean arterial pressure >106
mmHg, peripheral edema, pulmonary edema on chest radio-
graph), hemodynamically unstable subjects (those with car-
diac failure and frequent hypotension during hemodialysis),
infection, hemiplegia were excluded as were amputees and
those aged <18 yr. The studied patients have been on HD
therapy for a mean of 64 months (range 7-480 month) and
had a mean age of 57 yr (32-87). Some of the patients’ char-
acteristics are given in Table 1.
Dialysis technique
All patients underwent low-flux HD 3 times weekly with
bicarbonate buffer for 4 hr, 1.0- to 1.4-m2 hollow fiber poly-
sulfone membranes, blood flow rates of 250-280 mL/min
and dialysate flow rates of 500 mL/min, using the Fresenius
4008H machine (Germany) with a built-in ultrasonic blood
volume monitor. Ultrafiltration volume ranged from 270 to
3,940 mL, and treatment time was 4 hr. Dialysis fluid con-
tained sodium, 138 mEq/L; potassium, 2 mEq/L; calcium,
2.5 mEq/L; magnesium, 1.0 mEq/L; chloride, 108.5 mEq/L;
bicarbonate, 35 mEq/L; and glucose, 99.1 mg/dL, with the
temperature maintained at 36℃. Intradialytic hypotension
was defined as systolic blood pressure <90 mmHg or sys-
tolic blood pressure <100 mmHg with symptoms (nausea,
vomiting, sweating, dizziness, and yawning). 
Bioimpedance measurements
A multi-frequency BIA analyzer (Inbody BS1
�, Biospace
Co. Ltd, Seoul, Korea) was used to measure resistance or
impedance at 6 frequencies ranging between 1 kHz and 1
MHz. Eight tactile electrodes were in contact with surfaces
of both thumb, palm, front sole, and rear sole. This analyzer
is modeling body to 5 cylinders (right arm, left arm, trunk,
right leg and left leg). Segmental analysis by Inbody BS1
can not estimate ICF and ECF separately. After it measures
a resistance or impedance at frequencies ranging between 1
kHz and 1 MHz from each side, values of resistance or impe-
dance were calculated at all frequencies as follows (17).
1) arm (A)
RIA=arm length (cm
2)
RA ()
2) leg (L)
RIL=leg length (cm
2)
RL ()
3) trunk (T)
RIT=trunk height (cm
2)
RT ()
4) whole body (SUM)
RISUM=                  total body Ht (cm
2)
RRA ( )+RLA ( )+RT ( )+RRL ( )+RLL ()
Then, these data was exchanged to body fluid amounts
by means of BIA software. All patients were maintained in
the supine position. The measurements were repeated three
times and the average value was used for the data analysis.
The BIA measurements were taken immediately before HD
and each hour during HD session.
Blood volume monitoring
BVM was performed using a real-time online ultrasonic
blood volume monitor (Fresenius BVM, Germany). This ins-
trument measures the velocity of sound across flowing blood
by using a cuvette designed for this purpose in the extracor-
poreal circuit. The variability of the velocity of sound in this
system depends on changes in the density of total protein con-
tent (sum of plasma proteins and hemoglobin). Relative blood
volume at any given time may be determined from changes
in protein concentration relative to the initial starting value.
A high precision temperature measurement compensates for
the dependence of sound velocity on blood temperature. The
method has been validated as a precise and reliable measure-
ment of relative blood volume and has a very low noise signal
ratio (<0.2%) and a sampling rate as low as 3 sec. The tech-
nique has been compared against standard reference methods
involving serial measurements of hemoglobin and microcen-
trifuge hematocrit. The measurements were repeated three
times and the average value was used for the data analysis.
Statistical analysis
We expressed clinical data as mean±standard deviation.
Statistical tests used were repeated ANOVA, t-test and Kru-
skall-Wallis test for differences between means where appro-
priate. We converted the data of blood volume monitoring
Age (yr) 57 (32-87)
Male/female 14/10
Mean hemodialysis duration (month) 64 (7-480)
Mean hemodiaysis frequency (times/week) 3
Cause of CRF
Diabetes mellitus 10
Non-diabetic 14
Predialysis mean BP (mmHg) 156±26/83±9
Postdialysis mean BP (mmHg) 133±23/74±10
Body weight (kg) 55.9±11.3
Height (cm) 162±8.7
Mean UF (mL) 2,580±860
Table 1. Baseline characteristics (n=24)
Data represent mean±standard deviation or range.
SD, standard deviation; CRF, chronic renal failure; UF, ultrafiltration vol-
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to coordinates value (x, y) after setting up time to x axis, rela-
tive blood volume to y axis with Microsoft Excel 2000 pro-
gram at intervals of 5 min. Statistics and making graphs was
done with Microsoft Excel 2000 and SPSS package version
for Windows (SPSS Inc., Chicago, IL, U.S.A.).
RESULTS
Time course differences of blood volume, extracellular fluid,
intracellular fluid and volume of body compartments
Eighty four sets of data were obtained from 24 patients.
Relative change of blood volume was progressively reduced
from the start to the end of HD (1 hr, -7.22±3.23%; 2 hr,
-9.78±4.69%; 3 hr, -12.88±5.65%; 4 hr, -15.41±6.54%,
respectively) (Fig. 1). 
Fluid was removed from both extracellular and intracellular
compartments during HD. ECF was predominantly reduced
compared to ICF until 3 hr of HD ( ECF, -11.08±20.48%
vs. ICF,  -3.32±4.05%). After 3 hr of HD session, rela-
tive reduction of ICF became steep. Mean % reduction of
ICF was not significantly different to that of ECF at the end
of HD ( ICF, -5.69±6.15% vs.  ECF, -11.9±20.03%,
p value=0.064) (Fig. 1).
The fluid of arm, leg and trunk was significantly and pro-
gressively decreased from the start to the end of HD. % fluid
reduction of arms, legs and trunk was -13.1±13.97%, -7.26
±14.36% and -8.55±13.64%, respectively at the end of
HD. The fluid reduction of arms was the greatest but, there
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Fig. 1. Time course differences of blood volume, ICF, ECF. Rela-
tive change of blood volume is significantly reduced from the start
to the end of hemodialysis (1 hr, -7.22±3.23%; 2 hr, -9.78±4.69%;
3 hr, -12.88±5.65%; 4 hr, -15.41±6.54%, respectively). Extracellu-
alr fluid is predominantly reduced compared to intracellular fluid
until 3 hr of hemodialysis ( ECF, -6.37±5.88% vs.  ICF, -3.34
±2.83%,). After 3 hr of hemodialysis session, reduction of intra-
cellular fluid becomes steep. Mean % reduction of ICF is equal
to that of ECF at the end of hemodialysis ( ICF, -6.58±5.34%
vs. ECF,  -7.07±5.12%).
ICF, intracellular fluid; ECF, extracellular fluid.
Fig. 2. Time course differences of body compartments. The fluid
of arm, leg and trunk is significantly and progressively decreased
from the start to the end of hemodialysis. % fluid reduction of arms,
legs and trunk is -11.98±6.76%, -6.43±4.37% and -7.47±4.56%,
respectively at the end of hemodialysis. The fluid reduction of arms
is the greatest.
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Fig. 3. Three patterns in reduction of blood volume. (A) Type 1 is ‘‘continuous and linear reduction type’’. (B) Type 2 is ‘‘curvilinear reduction
type’’. (C) Type 3 is ‘‘early reduction and plasma refilling type’’.
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Time (min) A B Cwas no statistical defferences (p value=0.086) (Fig. 2).
The patterns in reduction of blood volume
There were 3 characteristic patterns in blood-volume change
(Fig. 3). Continuous and linear reduction, curvilinear, early
reduction and restoration of blood volume during HD is
classified to type 1, 2, 3, respectively. The patients of type 3
have higher ECF/TBW ratio and ECF/UF at the end of HD
session compared to those of type 1, 2 (0.42±0.01 vs. 0.36
±0.03, 0.33±0.06; 5.77±0.08 vs. 3.41±0.78, 3.29±
1.45, respectively) (Table 2).
DISCUSSION
Main findings of the present study were: First, that fluid
was similarly removed from both extracellular and intracel-
lular compartments at the end of HD and the % reduction
of segmental body fluid was arms, trunk and legs in order.
Second, we could find that there were 3 characteristic pat-
terns in the change of blood volume.
Available previous reports (9, 10) using BIA measurement
alone suggest that fluid is removed from both extracellular
and intracellular compartments during dialysis, with a pre-
dominance of ECF. Our data using BIA and BVM showed
that ECF was predominantly reduced compared to ICF until
3 hr of HD. After 3 hr of HD session, reduction curve of ICF
became steep. And then, mean % reduction of ICF was not
significantly different to that of ECF at the end of HD. These
results may suggest that fluid reduction during HD begins
in extracellular compartment, initially. After then, significant
fluid movement from intracellular to extracellular compart-
ment is followed at the last quarter of HD. Despite signifi-
cant movement of ICF into ECF, blood volume was contin-
uously reduced to the end of HD. This means that transferred
ICF may be remained in interstitial fluid (ISF) in HD patients
having clinically euvolemic status. According to the above
finding, there is a possibility that movement of ISF to vas-
cular space may start after session of HD in patients who do
not experience frequent intradialytic hypotension and have
volume overloading.
Whether the fluid is removed disproportionately from the
peripheral (arms, legs) or central (trunk) segments has been
assessed in two studies (15, 16). In the study of Shulman et
al. (15), BIA measurements after a standard 2 kg UF over
the first 75 min of dialysis indicated that more than 70% of
plasma refilling during HD comes from leg ECF, not central
ECF. Another study of Chanchairujira and Mehta (16) reached
conclusions that were at odds with the above. This study
found that approximately 60% of the ECF change during
HD occurred from the trunk rather than the extremities. It
is possible to reconcile that part of differences may be attribut-
ed to the timing when the bioimpedance measurements were
made: Shulman et al. performed the measurements 75 min
into dialysis, while Chanchairujira and Mehta obtained them
20-30 min after dialysis. The longer duration and greater
amount of UF in the Chanchairujira and Mehta study may
also have played a role. Therefore, we suggested that the rel-
ative fluid reduction of the arms is the largest is due to the
differences of the time interval of measuring BIA. To over-
come this fault, we conducted this study that both measure-
ments of BIA and BVM were taken immediately from the
start to the end of HD.
The percentage of segmental body fluid to reduced TBW
was trunk, legs, and arms in order. This contradictory result
is due to the absolute value of body fluid of trunk being the
largest.
Our results showed that the fluid of arm, leg and trunk
was significantly and progressively decreased from the start
to the end of HD. Relative % fluid reduction of extremities
was higher than that of trunk through-out HD sessions. Sur-
prisingly, relative % fluid reduction of arms was the greatest
according to the our data. When TBW and ECF measure-
ments using bioimpedance were compared to tracer dilution
techniques using deuterium oxide and sodium bromide, there
was poor agreement between the two methods of measure-
78 S.-J. Yu, D.-h Kim, D.-J. Oh, et al
Age (yr) 78±14 60±18 54±18 0.045
Male/female 9/3 4/6 1/1
Cause of CRF
Diabetes mellitus 4 4 1
non-diabetic 8 6 1
Mean HD duration   51±13 66±10 54±18 0.44
(month)
Kt/Vurea 1.25±0.25 1.25±0.19 1.55±0.14 0.21
Hypotensive event  2 5 0
in dialysis (times)
Mean UF (mL) 3012±439 2374±836 1011±1047 0.08
Dry weight (kg) 57.50±10.20 56.50±12.40 43.30±6.00 0.19
BMI (kg/m
2) 20.97±2.91 22.48±3.68 16.5±1.98 0.08
Number of antihy-
pertensive drug 1.8±1.5 1.6±1.7 1.0±1.4
Blood volume  10.01±4.98 10.49±3.83 2.13±1.56 0.361
change (%)
TBW change (%) 6.62±2.81 6.36±2.44 5.36±0.56 0.624
ECF change (%) 8.98±4.28 6.63±1.99 4.72±0.77 0.378
Post-HD ECF/ 0.36±0.06 0.33±0.03 0.42±0.004 0.001
TBW, ratio
Post-HD ECF/ 3.41±0.78 3.29±1.45 5.77±0.08 0.006
UF, ratio
Table 2. Clinical differences of 3 characteristic patterns in blood-
volume change
Data represent mean±standard deviation.
SD, standard deviation; CRF, chronic renal failure; HD, hemodialysis;
UF, ultrafiltration volume; BMI, body mass index; ECF, extracellular fluid;
TBW, total body water; ICF, intracellular fluid.
Type 1
(n=12,
36 times)
Type 2
(n=10,
30 times)
Type 3
(n=2,
6 times)
p
valuements (16). According to the Chanchairujira and Mehta’s
study, while both whole body and segmental bioimpedance
measurements can be used to track relative changes in TBW
and ECF in HD patients, they are both inaccurate in quan-
tifying absolute ECF volume. Thus, isolated measurements
of ECF and ICF by bioimpedance are of no value in clinical
practice. However, the reproducibility of measurements is
adequate, making bioimpedance a reasonable option to track
sequential changes in TBW and ECF (13). Our data showed
more relative and sequential fluid changes of HD compared
to previous results. And the data of previous studies (15, 16)
were the change of ECF in body compartments, while that
of our results were the change of TBW in body segments.
There were 3 characteristic patterns in continuous blood-
volume monitoring in our patients who were regarding as
clinically euvolemic patients. We can suggest that the patients
of type 1 are predictive of proximity to dry weight and the
likelihood of intradialytic hypotension with further weight
reduction. Type 2 patients have the most hypotensive events
among these three groups. The patients of type 3 have higher
ECF/TBW ratio, ECF/UF and lower ultrafiltration volume
at the end of HD session compared to those of type 1, 2. Above
finding means that the patients of type 3 are in excess of vol-
ume status. 
One result of previous studies showed that reduction in
relative blood volume at the hypotensive group was signifi-
cantly greater (18). However, different results were obtained
in another study. By Andrulli et al., intradialytic changes in
relative blood volume during HD cannot predict whether a
patient will be normotensive, prone to symptomatic hypoten-
sion, or hypertensive (19, 20). Baseline plasma-dialysate sodi-
um gradient, relative blood volume line irregularity, and
early relative blood volume reduction during dialysis influ-
enced the relative risk for symptomatic hypotension.
Our data support the partial use of BVM in chronic HD
patients as a tool both in preventing intradialytic hypoten-
sion and in identifying patients with volume overload who
could benefit from intensified ultrafiltration. While BVM
is easy to use and interpret, several limitations apply: blood
volume has no standardization (no absolute values exist, no
normality parameters for changes in blood volume are estab-
lished), and different pathophysiologic states can affect plas-
ma refilling. Thus, patients need to be monitored frequently
and sequentially to optimize results (14). Despite six time
measurements of blood volume in type 3 patients (n=2), a
potential limitation of the present study is the small and het-
erogeneous nature of the subject groups. Enrolled patients
underwent various times of BIA estimation and BVM mea-
surements. Thus we used eighty four sets of data obtained
from 24 patients, altogether. Therefore, to determine the rela-
tionship between blood volume monitoring and accurate vol-
ume status in the patient group, future studies will ideally
have larger and more homogeneous subject groups compared
to the present study.
In conclusions, the changes of body fluid at the end of HD
was similarly removed from both extracellular and intracel-
lular compartments and the % reduction of arms was the
greatest in chronic stable hemodialysis patients. The pattern
of blood-volume change measured by BVM be useful for
determining more accurate dry-weight and correcting vol-
ume status in patients with HD.
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